Arpa-h biomedical data fabric toolbox program
Active Awarded Last action
- Contract number
- 75N91024F00030
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $11,920,234
Award facts
- Contract value 100% obligated
- $11,920,234.00 Current and potential, with all options
- Completion date 64% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The U.S. National Cancer Institute (NCI) awarded a Delivery Order worth $11,920,234.00 to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract is for the ARPA-H BIOMEDICAL DATA FABRIC TOOLBOX PROGRAM, with an ultimate completion date of December 31, 2027. This award is part of Leidos Biomedical Research Inc.'s single-award Indefinite Delivery Contract with the NCI, valued at up to $6.6 billion over 5 years. The contract is a Cost Plus Fixed Fee arrangement and does not have a set-aside designation. Leidos Biomedical Research Inc. is an FFRDC contractor for the NCI, providing a range of biomedical research and facilities support services, including clinical trials management, manufacturing, and specialized laboratory testing. Through this Delivery Order, the company will continue to support the NCI's research initiatives in areas such as cancer, HIV/AIDS, influenza, COVID-19, and gene therapy.
Quick answers
Who was awarded contract 75N91024F00030?
75N91024F00030 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on August 31, 2024.
How much is contract 75N91024F00030 worth?
The government has obligated $11,920,234 on 75N91024F00030.
Is contract 75N91024F00030 an order under another contract?
Yes. 75N91024F00030 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91024F00030 competed?
The extent of competition for 75N91024F00030 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award